| 1 | COGT | Cogent Biosciences, Inc. | 10.04% |
| 2 | LIVN | LivaNova PLC | 6.61% |
| 3 | TVTX | Travere Therapeutics, Inc. | 5.26% |
| 4 | GH | Guardant Health, Inc. | 5.22% |
| 5 | TMDX | TransMedics Group, Inc. | 5.11% |
| 6 | MDGL | Madrigal Pharmaceuticals, Inc. | 4.24% |
| 7 | BBIO | BridgeBio Pharma, Inc. | 4.12% |
| 8 | SVRA | Savara Inc. | 3.88% |
| 9 | CORT | Corcept Therapeutics Incorporated | 3.40% |
| 10 | KALV | KalVista Pharmaceuticals, Inc. | 3.15% |
| 11 | UTHR | United Therapeutics Corporation | 3.03% |
| 12 | SYRE | Spyre Therapeutics, Inc. | 2.90% |
| 13 | TRVI | Trevi Therapeutics, Inc. | 2.89% |
| 14 | NKTR | Nektar Therapeutics | 2.86% |
| 15 | RDNT | RadNet, Inc. | 2.78% |
| 16 | INSM | Insmed Incorporated | 2.67% |
| 17 | WVE | Wave Life Sciences Ltd. | 2.60% |
| 18 | ICUI | ICU Medical, Inc. | 2.59% |
| 19 | ACAD | ACADIA Pharmaceuticals Inc. | 2.52% |
| 20 | MIRM | Mirum Pharmaceuticals, Inc. | 2.44% |
| 21 | RARE | Ultragenyx Pharmaceutical Inc. | 2.42% |
| 22 | COLL | Collegium Pharmaceutical, Inc. | 2.34% |
| 23 | ATEC | Alphatec Holdings, Inc. | 2.17% |
| 24 | AXSM | Axsome Therapeutics, Inc. | 1.86% |
| 25 | CBLL | CeriBell, Inc. | 1.53% |
| View LFSC holdings |